Angiotensin Converting Enzyme Gene Polymorphism in Alport Syndrome.
- Author:
Ji Hong KIM
1
;
Jae Seung LEE
;
Pyung Kil KIM
Author Information
1. Department of Pediatrics and The Institute of Kidney Disease, Yonsei University College of Medicine, Seoul, Korea. kkkjhd@yumc.yonsei.ac.kr
- Publication Type:Original Article
- Keywords:
Alport syndrome;
ACE gene polymorphism
- MeSH:
Age of Onset;
Angiotensins*;
Arm;
Child;
Collagen Type IV;
Disease Progression;
DNA;
Genotype;
Hearing Loss;
Humans;
Incidence;
Kidney Failure, Chronic;
Nephritis;
Nephritis, Hereditary*;
Peptidyl-Dipeptidase A*;
Polymerase Chain Reaction;
Polymorphism, Genetic;
Sex Ratio;
X Chromosome
- From:Journal of the Korean Society of Pediatric Nephrology
2004;8(1):18-25
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: Alport syndrome is clinically characterized by hereditary progressive nephritis causing ESRD with irregular thickening of the GBM and sensory neural hearing loss. The mutations of type IV collagen gene(COL4A5) located on the long arm of X chromosome is considered responsible for most of the structural abnormalities in the GBM of Alport patients. Since no definite clinical prognostic predictor has been reported in the disease yet, we designed this study to evaluate the significance of genetic polymorphism of the angiotensin converting enzyme in children with Alport syndrome as a prognostic factor for disease progression. METHODS: ACE I/D genotype were examined by PCR amplification of the genomic DNA in 12 patients with Alport syndrome and 12 of their family members. Alport patients were divided into two groups; the conservative group, those who had preserved renal function for more than 10 years of age, the early CRF group, those who had progressed to CRF within 10 years of age. RESULTS: The mean age of onset was 3.45+/-2.4 years in the conservative group, 4.4+/-1.2 years in the early CRF group. Sex ratios were 5:3 and 2:1 in each group. Among 12 cases of patients, 4 cases were in early CRF group and their mean duration of onset to CRF was 4.5 years(8.9 years of age). Eight patients(67%) were in the conservative group and they had normal renal function for more than 10 years of age(mean duration of renal preservation was 10.6 years). The incidence of II type ACE gene were in 25.0%(3 cases), ID type in 41.7 %(5 cases), DD type in 33.3%(4 cases). There was no significant difference between Alport patient and normal control(II type 44.3%, ID type 40.9%, DD type 14.8%). The incidence of DD type of early CRF group were higher than that of the conservative group(75% vs 12.5 %)(p<0.05). There was no difference in ACE gene polymorphism between normal Alport family members and control group. CONCLUSION: Even though there was no significant difference of ACE polymorphism between Alport patients and the normal control group, the incidence of DD type is significantly increased in early CRF group which means DD type of ACE polymorphism has a possibility of being a predictor for early progression to CRF in Alport patients.
